2-Methyl-4,6-dimethylthio-s-triazin | 5336-94-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 三嗪类
• 英文名称: 2-Methyl-4,6-dimethylthio-s-triazin
• 英文别名: 2-methyl-4,6-bis-methylsulfanyl-[1,3,5]triazine；methyl-bis-methylsulfanyl-[1,3,5]triazine；Methyl-bis-methylmercapto-[1,3,5]triazin；2-Methyl-4,6-bis(methylsulfanyl)-1,3,5-triazine
• CAS: 5336-94-7
• 化学式: C₆H₉N₃S₂
• 分子量: 187.29
• InChiKey: VYKOVZRWRPPVOT-UHFFFAOYSA-N

物化性质

• 熔点：
  72-73 °C
• 沸点：
  391.0±25.0 °C(Predicted)
• 密度：
  1.28±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.1
• 重原子数：
  11
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  89.3
• 氢给体数：
  0
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  2-Methyl-4,6-dimethylthio-s-triazin 在 镍 作用下， 生成 2-甲基-1,3,5-三嗪
  参考文献：
  名称：

  Triazines XV. The Conversion of Chloro-s-triazines into their Parent Compounds, s-Triazine and 2-Methyl-s-triazine^1,2

  摘要：

  DOI：

  10.1021/jo01112a013
• 作为产物：
  描述：

  2,4-二氯-6-甲基-1,3,5-三嗪 、 sodium thiomethoxide 生成 2-Methyl-4,6-dimethylthio-s-triazin
  参考文献：
  名称：

  Triazines XV. The Conversion of Chloro-s-triazines into their Parent Compounds, s-Triazine and 2-Methyl-s-triazine^1,2

  摘要：

  DOI：

  10.1021/jo01112a013

文献信息

• DRUG-CONJUGATES AND USES THEREOF
  申请人：Concortis Biosystems, Corp

  公开号：EP3925627A1

  公开（公告）日：2021-12-22

  In one aspect, an active agent-conjugate, methods of preparing the active agent-conjugate, and uses thereof is provided.

  一方面，提供了一种活性剂-共轭物、活性剂-共轭物的制备方法及其用途。
• KELAREV, V. I.;KARAXANOV, R. A.;MALYSHEV, V. A.;PATALAX, I. I., TEZ. DOKL. SEMIN.-SOVESHCH.-4 ZHOTREBITELI I PROIZVODITELI ORGAN. REAKTIV+
  作者：KELAREV, V. I.、KARAXANOV, R. A.、MALYSHEV, V. A.、PATALAX, I. I.

  DOI：——

  日期：——
• PERSONAL CARE AND HOUSEHOLD PRODUCT COMPOSITIONS COMPRISING SPECIFIC SULFUR CONTAINING STABILISER COMPOUNDS
  申请人：BASF SE

  公开号：EP2207522B1

  公开（公告）日：2019-11-06
• DRUG-CONJUGATES WITH A TARGETING MOLECULE AND TWO DIFFERENT DRUGS
  申请人：Miao Zhenwei

  公开号：US20150105540A1

  公开（公告）日：2015-04-16

  There is disclosed an improved ADC (antibody drug conjugate) type composition having at least two different drug payloads conjugated to a single targeting protein. More specifically, the present disclosure attaches a first drug conjugate to a dual Cysteine residue on a targeting protein and a second drug conjugate with a different drug to a Lys residue on the targeting protein.
• THREE-DIMENSIONAL INKJET PRINTING USING RING-OPENING METATHESIS POLYMERIZATION
  申请人：Stratasys Ltd.

  公开号：US20170306171A1

  公开（公告）日：2017-10-26

  Methods for fabricating three-dimensional objects by 3D-inkjet printing technology are provided. The methods utilize curable materials that polymerize via ring-opening metathesis polymerization (ROMP) for fabricating the object. Systems suitable for performing these methods and kits containing modeling material formulations usable in the methods are also provided.